188 related articles for article (PubMed ID: 35408859)
1. Autophagy Alteration in ApoA-I Related Systemic Amyloidosis.
Del Giudice R; Imbimbo P; Pietrocola F; Martins I; De Palma FDE; Bravo-San Pedro JM; Kroemer G; Maiuri MC; Monti DM
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408859
[TBL] [Abstract][Full Text] [Related]
2. Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations.
Gomaraschi M; Obici L; Simonelli S; Gregorini G; Negrinelli A; Merlini G; Franceschini G; Calabresi L
Clin Chim Acta; 2011 Jun; 412(13-14):1262-5. PubMed ID: 21458433
[TBL] [Abstract][Full Text] [Related]
3. Amyloidogenic variant of apolipoprotein A-I elicits cellular stress by attenuating the protective activity of angiogenin.
Del Giudice R; Monti DM; Sarcinelli C; Arciello A; Piccoli R; Hu GF
Cell Death Dis; 2014 Mar; 5(3):e1097. PubMed ID: 24603325
[TBL] [Abstract][Full Text] [Related]
4. Iowa Mutant Apolipoprotein A-I (ApoA-IIowa) Fibrils Target Lysosomes.
Kameyama H; Nakajima H; Nishitsuji K; Mikawa S; Uchimura K; Kobayashi N; Okuhira K; Saito H; Sakashita N
Sci Rep; 2016 Jul; 6():30391. PubMed ID: 27464946
[TBL] [Abstract][Full Text] [Related]
5. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
[TBL] [Abstract][Full Text] [Related]
6. The Apparent Organ-Specificity of Amyloidogenic ApoA-I Variants Is Linked to Tissue-Specific Extracellular Matrix Components.
Del Giudice R; Lindvall M; Nilsson O; Monti DM; Lagerstedt JO
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613763
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-I induced amyloidosis.
Genschel J; Haas R; Pröpsting MJ; Schmidt HH
FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
[TBL] [Abstract][Full Text] [Related]
8. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
[TBL] [Abstract][Full Text] [Related]
10. Protein conformational perturbations in hereditary amyloidosis: Differential impact of single point mutations in ApoAI amyloidogenic variants.
Del Giudice R; Arciello A; Itri F; Merlino A; Monti M; Buonanno M; Penco A; Canetti D; Petruk G; Monti SM; Relini A; Pucci P; Piccoli R; Monti DM
Biochim Biophys Acta; 2016 Feb; 1860(2):434-44. PubMed ID: 26515634
[TBL] [Abstract][Full Text] [Related]
11. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
[TBL] [Abstract][Full Text] [Related]
12. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
[TBL] [Abstract][Full Text] [Related]
13. The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
Obici L; Bellotti V; Mangione P; Stoppini M; Arbustini E; Verga L; Zorzoli I; Anesi E; Zanotti G; Campana C; Viganò M; Merlini G
Am J Pathol; 1999 Sep; 155(3):695-702. PubMed ID: 10487826
[TBL] [Abstract][Full Text] [Related]
14. Light Chain Amyloidosis-Induced Autophagy Is Mediated by the Foxo3a/Beclin-1 Pathway in Cardiomyocytes.
Zhang Y; Yu W; Chang W; Wang M; Zhang L; Yu F
Lab Invest; 2023 Feb; 103(2):100001. PubMed ID: 37039144
[TBL] [Abstract][Full Text] [Related]
15. Fibrillar conformation of an apolipoprotein A-I variant involved in amyloidosis and atherosclerosis.
Gisonno RA; Prieto ED; Gorgojo JP; Curto LM; Rodriguez ME; Rosú SA; Gaddi GM; Finarelli GS; Cortez MF; Schinella GR; Tricerri MA; Ramella NA
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129515. PubMed ID: 31904503
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
Gursky O; Mei X; Atkinson D
Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
[TBL] [Abstract][Full Text] [Related]
17. Mutation mapping of apolipoprotein A-I structure assisted with the putative cholesterol recognition regions.
Dergunov AD
Biochim Biophys Acta; 2013 Oct; 1834(10):2030-5. PubMed ID: 23806608
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death.
Thellung S; Scoti B; Corsaro A; Villa V; Nizzari M; Gagliani MC; Porcile C; Russo C; Pagano A; Tacchetti C; Cortese K; Florio T
Cell Death Dis; 2018 Feb; 9(2):166. PubMed ID: 29416016
[TBL] [Abstract][Full Text] [Related]
19. High-efficient bacterial production of human ApoA-I amyloidogenic variants.
Del Giudice R; Lagerstedt JO
Protein Sci; 2018 Dec; 27(12):2101-2109. PubMed ID: 30291643
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
